Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndrome (MDS)

NCT00038805 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: Mylotarg

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]